Publications by authors named "Anne Fane"

Claim this Profile
E
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
Nicholas Paul Casey, Clara Helena Klee, Anne Fåne, Benjamin Caulier, Agnieszka Graczyk-Jarzynka

J Biol Chem· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
Nadia Mensali, Hakan Köksal, Sandy Joaquina, Patrik Wernhoff, Nicholas P Casey

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo experimental mouse model to test CD19CAR T cells generated with different methods.
Anne Fåne, Marit Renée Myhre, Else Marit Inderberg, Sebastien Wälchli

Methods Cell Biol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma.
Hakan Köksal, Pierre Dillard, Sarah E Josefsson, Solrun Melkorka Maggadottir, Sylvie Pollmann

Blood Adv· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK cells specifically TCR-dressed to kill cancer cells.
Nadia Mensali, Pierre Dillard, Michael Hebeisen, Susanne Lorenz, Theodossis Theodossiou

EBioMedicine· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination.
Jon Amund Kyte, Anne Fåne, Martin Pule, Gustav Gaudernack

Oncoimmunology· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human c-SRC kinase (CSK) overexpression makes T cells dummy.
Else Marit Inderberg, Nadia Mensali, Morten P Oksvold, Lars-Egil Fallang, Anne Fåne

Cancer Immunol Immunother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A TCR-based Chimeric Antigen Receptor.
Even Walseng, Hakan Köksal, Ibrahim M Sektioglu, Anne Fåne, Gjertrud Skorstad

Sci Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.
Celia McNeilly, Samantha Cosh, Therese Vu, Jemma Nichols, Anna Henningham, Anne Fane

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia.
Jodie L Morris, Anne Fane, Derek S Sarovich, Erin P Price, Catherine M Rush

Emerg Infect Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate.
Michael R Batzloff, Anne Fane, Davina Gorton, Manisha Pandey, Tania Rivera-Hernandez

Hum Vaccin Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease.
Hanne Astrid Eide, Ann Rita Halvorsen, Vandana Sandhu, Anne Fåne, Janna Berg

Clin Transl Immunology· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotropic threat characterization of Burkholderia pseudomallei strains.
Jodie Morris, Anne Fane, Catherine Rush, Brenda Govan, Mark Mayo

Emerg Infect Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis